Clinical Trial Update: A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A [NA]

View source ↗

Summary

This is a continuation study to monitor the long-term safety of patients who completed AcuFocus protocol ACU-P08-020/020A for presbyopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• KAMRA inlay (corneal inlay)

Snippet

Sponsor: AcuFocus, Inc. | Conditions: Presbyopia | NA | Status: COMPLETED | Results posted: 2017-06-28